论文部分内容阅读
2005年5月26-28日在沈阳召开了中国风湿病学术年会,重视结缔组织病肺间质纤维化和肺动脉高压是本次会议的主题之一。通过本次会议的讨论,希望能引起大家对结缔组织病肺间质病变和肺动脉高压的认识。中华医学会风湿病学分会主任委员张奉春教授指出,结缔组织病是全身多系统受累的疾病,以往大家把更多关注的目光放在肾脏受累、中枢神经系统受累和继发感染上,在这些问题研究及治疗的进展使弥漫性结缔组织病的生存期得到很大的改善。实际上肺间质纤维化和肺动脉高压也是结缔组织病预后不好的一个重要因素,长期以来未受到应有的重视。因此,加强对肺间质病变和肺动脉高压的研究是又一个提高结缔组织病预后的关键。
May 26-28, 2005 held in Shenyang, China rheumatic academic annual meeting, attach importance to connective tissue disease pulmonary interstitial fibrosis and pulmonary hypertension is one of the topics of this meeting. Through the discussion of this meeting, I hope to arouse people’s understanding of connective tissue interstitial lung disease and pulmonary hypertension. Professor Zhang Fengchun, chairman of the Chinese Medical Association Rheumatology Branch, pointed out that connective tissue disease is a systemic systemic disease. In the past, more attention was paid to kidney involvement, CNS involvement and secondary infection. In these problems The progress of research and treatment of diffuse connective tissue disease survival rate has been greatly improved. In fact pulmonary interstitial fibrosis and pulmonary hypertension is also an important factor in the poor prognosis of connective tissue disease, which has not been given due attention for a long time. Therefore, to strengthen the study of interstitial lung disease and pulmonary hypertension is another key to improve the prognosis of connective tissue disease.